The historical rank and industry rank for Baijin Life Science Holdings's Net Margin % or its related term are showing as below:
MNNGF'
s Net Margin % Range Over the Past 10 Years
Min: -251.68 Med: -19.28 Max: 9.99
Current: 6.75
MNNGF's Net Margin % is ranked better than 75.62% of 1128
companies
in the Retail - Cyclical industry
Industry Median: 2.33
vs MNNGF: 6.75
Baijin Life Science Holdings (OTCPK:MNNGF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Baijin Life Science Holdings Net Margin % Related Terms
Baijin Life Science Holdings Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Net Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a Net Margin % of 3.94% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Baijin Life Science Holdings and its competitors. According to the industry distribution chart, Baijin Life Science Holdings ranks #275 out of 1128 companies in the Retail - Cyclical industry, placing it in the top 24.4%.
Is Baijin Life Science Holdings' Net Margin % too high?
Baijin Life Science Holdings' current Net Margin % is 3.94%. The Retail - Cyclical industry median Net Margin % is 2.33. Baijin Life Science Holdings' value of 3.94% is 69.1% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #275 out of 1128 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Net Margin % compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #275 out of 1128 companies for Net Margin %. This places Baijin Life Science Holdings in the top 24% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.33. Baijin Life Science Holdings' value of 3.94% is 69.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Retail - Cyclical company?
The median Net Margin % among Retail - Cyclical companies is 2.33, based on 1,128 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Net Margin % of 3.94% is 69.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Net Margin % is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Net Margin % is 3.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Net Margin % of 3.94%. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Net Margin % is 3.94% and 69.1% above the Retail - Cyclical industry median of 2.33. Baijin Life Science Holdings' overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Net Margin % is 3.94% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.
Key valuation signals for MNNGF:
Net Margin %: 3.94%
GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
Industry Position: 69.1% above the Retail - Cyclical median (#275 of 1128)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
35GF Score
Get the complete analysis for MNNGF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
